176 related articles for article (PubMed ID: 30088872)
21. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
22. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis.
Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y
Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879
[TBL] [Abstract][Full Text] [Related]
23. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
24. Composition of major quinochalcone hydroxysafflor yellow A and anhydrosafflor yellow B is associated with colour of safflower (Carthamus tinctorius) during colour-transition but not with overall antioxidant capacity: A study on 144 cultivars.
Yan Z; Alimu R; Wan J; Liao X; Lin S; Dai S; Chen F; Zhang S; Tong Y; Liu H; Qin R; Liu J
Food Res Int; 2022 Dec; 162(Pt B):112098. PubMed ID: 36461404
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
Xia L; Chen XM; Peng LR; Wang SX; Wang XW; Zuo Y; Zhang P; Liu QS; Zheng XH
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):269-72. PubMed ID: 23672054
[TBL] [Abstract][Full Text] [Related]
26. NMR solution structure study of the representative component hydroxysafflor yellow A and other quinochalcone C-glycosides from Carthamus tinctorius.
Feng ZM; He J; Jiang JS; Chen Z; Yang YN; Zhang PC
J Nat Prod; 2013 Feb; 76(2):270-4. PubMed ID: 23387865
[TBL] [Abstract][Full Text] [Related]
27. Hormone-sensitive lipase is involved in the action of hydroxysafflor yellow A (HYSA) inhibiting adipogenesis of 3T3-L1cells.
Zhu HJ; Wang LJ; Wang XQ; Pan H; Li NS; Yang HB; Jin M; Zang BX; Gong FY
Fitoterapia; 2014 Mar; 93():182-8. PubMed ID: 24440907
[TBL] [Abstract][Full Text] [Related]
28. [Determination of safflor yellow A by RP-HPLC and resources quality comparison in Carthamus tinctorius].
Guo ML; Zhang G; Zhang W; Zhang HM; Su ZW
Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(15):1234-6. PubMed ID: 17048563
[TBL] [Abstract][Full Text] [Related]
29. Screening antiallergic components from Carthamus tinctorius using rat basophilic leukemia 2H3 cell membrane chromatography combined with high-performance liquid chromatography and tandem mass spectrometry.
Han S; Huang J; Cui R; Zhang T
J Sep Sci; 2015 Feb; 38(4):585-91. PubMed ID: 25521715
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor yellow A triggered a fast-to-slow muscle fiber-type conversion
Sun Y; Wang Z; Nie C; Xue L; Wang Y; Liu J; Fan M; Zhang D; He R; Zhang X; Qian H; Chow BKC; Li Y; Wang L
Food Funct; 2022 Jun; 13(11):6317-6328. PubMed ID: 35611953
[TBL] [Abstract][Full Text] [Related]
31. Hydroxysafflor yellow A attenuates lymphostatic encephalopathy-induced brain injury in rats.
Pan Y; Zheng DY; Liu SM; Meng Y; Xu HY; Zhang Q; Gong J; Xia ZL; Chen LB; Li HY
Phytother Res; 2012 Oct; 26(10):1500-6. PubMed ID: 22318911
[TBL] [Abstract][Full Text] [Related]
32. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Wang J; Zhang Q; Mei X; Zhang X
Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice.
Yao R; Cao Y; Jiang R; Zhang X; Li F; Wang S
Biomed Chromatogr; 2021 Oct; 35(10):e5173. PubMed ID: 33982286
[TBL] [Abstract][Full Text] [Related]
34. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
[TBL] [Abstract][Full Text] [Related]
35. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
Molecules; 2018 May; 23(5):. PubMed ID: 29783643
[TBL] [Abstract][Full Text] [Related]
36. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.
Wang Y; Zhang C; Peng W; Xia Z; Gan P; Huang W; Shi Y; Fan R
Mol Med Rep; 2016 Oct; 14(4):3690-6. PubMed ID: 27599591
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
[TBL] [Abstract][Full Text] [Related]
38. Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase.
Xu Y; Lee J; Park YD; Yang JM; Zheng J; Zhang Q
J Biomol Struct Dyn; 2018 Mar; 36(4):830-840. PubMed ID: 28264629
[TBL] [Abstract][Full Text] [Related]
39. [Functional characterization and enzymatic properties of flavonoid glycosyltransferase gene CtUGT49 in Carthamus tinctorius].
Cai XB; Liu N; Li J; Liu R; Luo YF; Zhang YF; Wang JD; Wu XY; Huang LQ
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6624-6634. PubMed ID: 38212022
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
